ArticleFrontiers in pharmacology2020

Characterization of Corosolic Acid as a KPC-2 Inhibitor That Increases the Susceptibility of KPC-2-Positive Bacteria to Carbapenems.

Yonglin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.